Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valganciclovir vs Ganciclovir in CMV Retinitis
NCT00002377Phase 3Completed
- Sponsor
- Roche
- Start
- Jan 1997
- Primary completion
- Dec 2002
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of valganciclovir in cytomegalovirus retinitis, sponsored by Roche. Started Jan 1997; status: completed.
02
Drugs
valganciclovir
03
Conditions
cytomegalovirus retinitis
Beyond the preview
Go deeper on NCT00002377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002377.